paperKB
coga / coga-kb
Help
Sign in

Chunk #32 — 4. Medication and Functional and Affective Syndrome Changes over Time of Bipolar Groups

Source
A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset.
Embedded
yes

Text

While there was no difference across groups in the rate of subjects receiving medication during their most severe affective episode, subjects were prescribed antidepressants (35%), benzodiazepines (16%), neuroleptics (18%), lithium (9%), anticonvulsants (13%), or a combination of these medications (23%). At the follow-up interview, no differences were found across groups in type and rate of medication for the treatment of the most severe affective episode. Patients were prescribed antidepressants (31%), benzodiazepines (8%), neuroleptics (13%), lithium (35%), and anticonvulsants (22%). At follow-up, 35% of the bipolar subjects in all groups took a combination of these compounds.